Skip to main content
logo
InventisBio Co., Limited (SHA:688382)
China flag China · Delayed Price · Currency is CNY
19.60
+0.34 (1.77%)
Sep 8, 2026, 4:00 PM EDT

InventisBio Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
71.4437.29168.79185.53--
Revenue Growth
-58.72%-77.91%-9.02%---
Gross Profit
65.9532.27164.87185.53--
Operating Income
-373.75-351.49-280.95-327.65-519.44-362.8
Net Income
-334.51-316.87-240.2-283.98-483.49-357.91
Earnings Per Share
-0.58-0.55-0.42-0.49-0.95-0.78
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,3271,5351,6871,9192,235724.25
Total Debt
18.822.0723.9211.6227.3423.66
Net Cash (Debt)
1,3091,5131,6631,9082,208700.6
Net Cash Growth
-16.14%-9.06%-12.82%-13.59%215.14%-32.20%
Net Cash Per Share
2.272.632.913.324.341.53

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-236.14-155.44-241.97-307.75-476.89-252.07
Capital Expenditures
-7.3-6.92-7.56-6.29-7.69-26.52
Free Cash Flow
-243.44-162.36-249.53-314.04-484.59-278.59
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
92.31%86.54%97.67%100.00%--
Operating Margin
-523.13%-942.59%-166.45%-176.61%--
Pretax Margin
-468.16%-849.10%-142.31%-153.06%--
Profit Margin
-468.21%-849.74%-142.31%-153.06%--
FCF Margin
-340.73%-435.41%-147.84%-169.27%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
159.00422.4845.4546.92--